Pair Name | Morin, Auranofin | ||
Phytochemical Name | Morin (PubChem CID: 5281670 ) | ||
Anticancer drug Name | Auranofin (PubChem CID: 24199313 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Morin, Auranofin | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Induction-->ROS generation | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Down-regulation | Expression | BIRC2 | hsa329 | |
Down-regulation | Expression | BIRC3 | hsa330 | |
Down-regulation | Expression | CASP3 | hsa836 | |
Down-regulation | Expression | CASP8 | hsa841 | |
Down-regulation | Expression | CASP9 | hsa842 | |
Up-regulation | Expression | CYCS | hsa54205 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Up-regulation | Expression | TNFRSF10A | hsa8797 | |
Up-regulation | Expression | TNFRSF10B | hsa8795 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens (Human) | CVCL_0326 |
Result | This study provides evidence that morin can enhance the anticancer activity of AF in Hep3B human hepatocellular carcinoma cells, indicating that its combination could be an alternative treatment strategy for the hepatocellular carcinoma. |
No. | Title | Href |
---|---|---|
1 | Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells. Phytother Res. 2019 May;33(5):1384-1393. doi: 10.1002/ptr.6329. | Click |